(Q38047250)

27 August 2017

title

Why imatinib remains an exception of cancer research (English)

1 reference

27 August 2017

1 reference

Steven D Horne

1

1 reference

27 August 2017

Joshua B Stevens

2

1 reference

27 August 2017

Batoul Y Abdallah

3

1 reference

27 August 2017

Guo Liu

4

1 reference

27 August 2017

Steven W Bremer

5

1 reference

27 August 2017

Christine J Ye

6

1 reference

27 August 2017

Henry H Q Heng

7

1 reference

27 August 2017

publication date

1 April 2013

1 reference

Journal of Cellular Physiology

27 August 2017

published in

1 reference

27 August 2017

volume

228

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

665-670

1 reference

Chromosome aberrations in solid tumors

27 August 2017

cites work

1 reference

Monitoring response and resistance to treatment in chronic myeloid leukemia

21 January 2018

1 reference

The genomic complexity of primary human prostate cancer

21 January 2018

1 reference

Human cancers express a mutator phenotype

21 January 2018

1 reference

Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group

21 January 2018

1 reference

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

Acute promyelocytic leukaemia: novel insights into the mechanisms of cure

21 January 2018

1 reference

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

21 January 2018

1 reference

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

Problems of somatic mutation and cancer

21 January 2018

1 reference

21 January 2018

1 reference

Lessons from applied ecology: cancer control using an evolutionary double bind.

21 January 2018

1 reference

Evolutionary dynamics of cancer prevention

21 January 2018

1 reference

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

The fate of competing beneficial mutations in an asexual population.

21 January 2018

1 reference

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.

21 January 2018

1 reference

Evolutionary dynamics of carcinogenesis and why targeted therapy does not work.

21 January 2018

1 reference

Results from a monocentric phase II trial of erlotinib in patients with metastatic prostate cancer

21 January 2018

1 reference

EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for Treatment

21 January 2018

1 reference

Acute leukaemia in bcr/abl transgenic mice

21 January 2018

1 reference

Cancer genome sequencing: the challenges ahead

21 January 2018

1 reference

Imaging genome abnormalities in cancer research

21 January 2018

1 reference

Cancer progression by non-clonal chromosome aberrations

21 January 2018

1 reference

Clonal and non-clonal chromosome aberrations and genome variation and aberration.

21 January 2018

1 reference

Stochastic cancer progression driven by non-clonal chromosome aberrations.

21 January 2018

1 reference

Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective

21 January 2018

1 reference

Genetic and epigenetic heterogeneity in cancer: the ultimate challenge for drug therapy

21 January 2018

1 reference

Evolutionary mechanisms and diversity in cancer

21 January 2018

1 reference

Karyotype heterogeneity and unclassified chromosomal abnormalities

21 January 2018

1 reference

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy

21 January 2018

1 reference

Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

21 January 2018

1 reference

Reversibility of acute B-cell leukaemia induced by BCR-ABL1.

21 January 2018

1 reference

Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history.

21 January 2018

1 reference

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

21 January 2018

1 reference

Imatinib spells BAD news for Bcr/abl-positive leukemias

21 January 2018

1 reference

A causal role for ERG in neoplastic transformation of prostate epithelium.

21 January 2018

1 reference

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

Evolution of intratumoral genetic heterogeneity during colorectal cancer progression.

21 January 2018

1 reference

Principles of cancer therapy: oncogene and non-oncogene addiction

21 January 2018

1 reference

Cancer as an evolutionary and ecological process

21 January 2018

1 reference

Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States

21 January 2018

1 reference

Tumour evolution inferred by single-cell sequencing

21 January 2018

1 reference

Chromosome instability in malignant astrocytic tumors detected by fluorescence in situ hybridization

21 January 2018

1 reference

The clonal evolution of tumor cell populations

21 January 2018

1 reference

Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small-cell lung cancer: a meta-analysis of 13 randomized trials

21 January 2018

1 reference

The Biology of CML blast crisis

21 January 2018

1 reference

Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers

21 January 2018

1 reference

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

21 January 2018

1 reference

Common gene rearrangements in prostate cancer

21 January 2018

1 reference

Prognostic utility of chromosomal instability detected by fluorescence in situ hybridization in fine-needle aspirates from oral squamous cell carcinomas

21 January 2018

1 reference

Epidermal growth factor receptor mutations in lung cancer

21 January 2018

1 reference

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

21 January 2018

1 reference

Chronic myeloid leukemia cells refractory/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease state

21 January 2018

1 reference

A multicenter phase II clinical trial of lapatinib (GW572016) in hormonally untreated advanced prostate cancer

21 January 2018

1 reference

Diverse system stresses: common mechanisms of chromosome fragmentation.

21 January 2018

1 reference

Heterogeneity of cell death

21 January 2018

1 reference

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

Role of the TMPRSS2-ERG gene fusion in prostate cancer

21 January 2018

1 reference

Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues

21 January 2018

1 reference

Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer.

21 January 2018

1 reference

Acute promyelocytic leukemia: new issues on pathogenesis and treatment response

21 January 2018

1 reference

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling

21 January 2018

1 reference

The dynamics of cancer chromosomes and genomes

21 January 2018

1 reference

Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer

21 January 2018

1 reference

Genomic instability and rapid clinical course in adult T-cell lymphoma/leukemia patient.

21 January 2018

1 reference

Chronic myeloid leukemia: current perspectives

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCP.24233

1 reference

27 August 2017

1 reference